Cohance Lifesciences Board Approves Q1 FY27 Unaudited Results

Cohance Lifesciences Ltd announced that its Board of Directors, in a meeting held on August 5, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved reorganization at its subsidiary, Sapala Organics Private Limited, and decided to convene the 8th Annual General Meeting on September 17, 2026. The financial results, limited review reports, press release, and investor presentation were enclosed with the filing. The meeting commenced at 3:30 pm IST and concluded at 5:25 pm IST.